AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday, with the strongest response seen in people who received two doses. Lauren Anthony reports.
Health
Early trials of U.K. COVID-19 vaccine shows promise
More Videos
-
Ozempic maker bringing weight-loss drug Wegovy to Canada
-
Health Matters: Newfoundland and Labrador work to hire, retain nurses through incentives
-
Toxic metals in vapes linked with major health problems in youth, study finds
-
Ozempic-makers’ weight-loss drug, Wegovy, coming soon to Canada
-
Weight-loss drug Wegovy available in Canada starting May 6
-
Health Matters: Caregiver report highlights need for help
You are viewing an Accelerated Mobile Webpage.
View Original Article